Oncogenic osteomalacia associated with mesenchymal tumor in the middle cranial fossa: A case report

被引：10

作者：

Isao Chokyu

Kenichi Ishibashi

Takeo Goto

Kenji Ohata

机构：

[1] Department of Neurosurgery, Osaka City University, Graduate School of Medicine, Abeno-ku, Osaka, 545-8585

来源：

Journal of Medical Case Reports | / 6卷 / 1期

关键词：

Osteomalacia; Giant Cell Tumor; Hypophosphatemia; Middle Cranial Fossa; Serum Phosphate Level;

D O I：

10.1186/1752-1947-6-181

中图分类号：

学科分类号：

摘要：

Introduction. Tumor-induced osteomalacia is a paraneoplastic syndrome of hypophosphatemia. Osteomalacia causes multiple bone fractures and severe pain. Case presentation. We report the case of a 57-year-old Japanese man with tumor-induced osteomalacia associated with a middle cranial fossa bone tumor. The tumor was successfully resected by using a middle fossa epidural approach. His phosphate level recovered to a normal range immediately after the surgery. Conclusions: It is rare that tumor-induced osteomalacia originates from the middle skull base. This report suggests that, if patients have a clinical and biochemical picture suggestive of tumor-induced osteomalacia, it is crucial to perform a meticulous examination to detect the tumor or the lesion responsible for the tumor. The serum level of fibroblast growth factor 23 is the most reliable marker for evaluating the treatment outcome of tumor-induced osteomalacia. © 2012 Chokyu et al.; licensee BioMed Central Ltd.

引用

共 10 条

[1]

Jan De Beur S.M., Tumor-induced osteomalacia, Journal of the American Medical Association, 294, 10, pp. 1260-1267, (2005)

[2]

David K., Revesz T., Kratimenos G., Krausz T., Crockard H.A., Oncogenic osteomalacia associated with a meningeal phosphaturic mesenchymal tumor. Case report, J Neurosurg, 84, pp. 288-292, (1996)

[3]

Folpe A.L., Fanburg-Smith J.C., Billings S.D., Bisceglia M., Bertoni F., Cho J.Y., Econs M.J., Inwards C.Y., Jan De Beur S.M., Mentzel T., Montgomery E., Michal M., Miettinen M., Mills S.E., Reith J.D., O'Connell J.X., Rosenberg A.E., Rubin B.P., Sweet D.E., Vinh T.N., Wold L.E., Wehrli B.M., White K.E., Zaino R.J., Weiss S.W., Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic Entity: An Analysis of 32 Cases and a Comprehensive Review of the Literature, American Journ

[4]

Kumar R., Tumor-induced osteomalacia and the regulation of phosphate homeostasis, Bone, 27, 3, pp. 333-338, (2000)

[5]

McCance R.A., Osteomalacia with Loosers nodes (Milkmans syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years, Q J Med, 16, pp. 33-46, (1947)

[6]

Crouzet J., Mimoune H., Beraneck L., Juan L.H., Hypophosphatemic osteomalacia with plantar neurilemoma. A review of the literature (100 cases), Rev Rhum Engl Ed, 62, pp. 463-466, (1995)

[7]

Gonzalez-Compta X., Manos-Pujol M., Foglia-Fernandez M., Peral E., Condom E., Claveguera T., Dicenta-Sousa M., Oncogenic osteomalacia: Case report and review of head and neck associated tumours, Journal of Laryngology and Otology, 112, 4, pp. 389-392, (1998)

[8]

Pirola E., Vergani F., Casiraghi P., Leone E.B., Guerra P., Sganzerla E.P., Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine, J Neurosurg Spine, 10, pp. 329-333, (2009)

[9]

Carpenter T.O., Oncogenic osteomalacia - A complex dance of factors, New England Journal of Medicine, 348, 17, pp. 1705-1708, (2003)

[10]

Fukumoto S., Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism [in Japanese], Rinsho Byori, 55, pp. 555-559, (2007)

← 1 →